Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
10.1016/j.gore.2018.01.009
Saved in:
Main Authors: | Ngoi, NYL, Heong, V, Lee, XW, Huang, YQ, Thian, YL, Choo, BA, Lim, D, Lim, YW, Lim, SE, Ilancheran, A, Soong, R, Tan, DSP |
---|---|
Other Authors: | DIAGNOSTIC RADIOLOGY |
Format: | Article |
Published: |
Elsevier BV
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206422 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The role of immunotherapy in the treatment of advanced cervical cancer: Current status and future perspectives
by: Walsh, RJ, et al.
Published: (2021) -
IMWG consensus on risk stratification in multiple myeloma
by: Chng, W.J., et al.
Published: (2016) -
Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
by: Sundar, R, et al.
Published: (2019) -
Digital biomarkers for depression screening with wearable devices: cross-sectional study with machine learning modeling
by: Rykov, Yuri, et al.
Published: (2022) -
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
by: Ngoi, Natalie YL, et al.
Published: (2021)